Business
AstraZeneca vaccine volunteer developed spinal inflammation & ‘rare neurological condition’ after two doses – report – RT
A British participant in AstraZeneca’s coronavirus vaccine trial was diagnosed with a serious neurological disorder weeks after her second dose of the inoculation, an internal company document shows.
A previously healthy 37-year-old woman was hospitalized this month after receiving two injections of the pharmaceutical giant’s new vaccine, where it was determined she developed transverse myelitis, a rare neurological ailment caused by inflammation of the spine, according to an internal AstraZeneca safety report obtained by CNN.
Though the report states the woman, who has not been identified by name, had no adverse reaction after her first dose in early June, she began to experience neurologi…
-
Noosa News22 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News23 hours agoForum responds to urgent homelessness issues in Nambour
-
Business20 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Business21 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?